Simvastatin in the elderly
WebbStatin use has been found to modestly increase blood glucose levels, leading to worsening of diabetes and increase the risk of developing diabetes mellitus. 18 One study reported … Webb1 nov. 2024 · Simvastatin modified surface adhesion molecule expression and activity, facilitating accurate migration in the elderly. Conclusions Infections in older adults are associated with prolonged, impaired neutrophil migration, potentially contributing to …
Simvastatin in the elderly
Did you know?
WebbSimvastatin in the treatment of hypercholesterolemia in elderly patients Twenty elderly (mean age, 69 years), hypercholesterolemic patients (low-density lipoprotein [LDL] levels greater than or equal to 160 mg/dl) were supplied a lipid-lowering diet for one month and then received 10 mg of simvastatin daily for 12 months. Webb29 okt. 2024 · Similarly, an Israeli study, also published in 2024, in the Journal of the American Geriatrics Society, found that older people who adhered to their statin prescription had a 34 percent lower chance of an early death from any cause than those who stopped taking the drug.
Webb4 feb. 2024 · Statin therapy is safe in the elderly and has no effect at any age on nonvascular mortality, cancer death, or cancer incidence. In persons >75 years, the absolute reduction in vascular events was about 0.5% per year per mmol/L decrease in LDL-C, which may or may not be greater in high-risk subjects. Webb1 okt. 2024 · The primary outcomes include dementia and physical disability over 4 years. Meanwhile, the STAREE trial will assess the efficacy of atorvastatin 40 mg daily versus placebo in the improvement of overall survival or disability-free survival in 18,000 …
Webb24 jan. 2024 · The elderly suffer not only more advanced and complex changes of cardiovascular system but, also, other chronic conditions. Moreover, compared to middle-age, different therapeutic response is often observed due to changes of pharmaco-kinetics and -dynamics; these patients use other medications, which may trigger drug interactions. Webb12 apr. 2024 · Moderate-intensity statin with ezetimibe combination therapy was associated with lower rates of intolerance-related drug discontinuation or dose reduction among patients aged ≥75 years (2.3% vs. 7.2%; p = 0.010) and those aged <75 years (5.2% vs. 8.4%; p < 0.001) (p for interaction = 0.159). Median LDL-C levels were 58 mg/dL in the ...
Webb26 jan. 2024 · Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of simvastatin in the elderly. However, elderly patients are more likely to have age-related liver, kidney, heart, or muscle problems (eg, myopathy and rhabdomyolysis), which may require caution in patients receiving …
Webb12 nov. 2024 · In the entire cohort of individuals aged 20 to 100 years old, each 1-mmol/L increase in LDL cholesterol was associated with a 34% increased risk of MI and a 16% increased risk of ASCVD, and these risks were observed across all age groups. For the older patients, specifically those aged 70-79 and 80-100 years, each 1-mmol/L increase … csot medtronicWebb30 mars 2024 · Scandinavian Simvastatin Survival Study group Randomized controlled trial of cholesterol lowering in 4444 patients with ... Alacqua M, Corrao S, Tari M, Arcoraci V. Statins for the primary prevention of cardiovascular events in elderly patients: a picture from clinical practice without strong evidence from clinical trials. J ... cso theatreWebb6 okt. 2004 · In the Scandinavian Simvastatin Survival Study (4S), simvastatin treatment reduced cardiac mortality by 42% in the diabetic cohort. The most ... particularly in elderly patients. However, efforts to publicize the benefits of statin therapy in diabetes are making inroads into prescribing patterns. In the ... csot medwayWebb19 dec. 2024 · The drugs that doctors use to treat the new disease are called statins–sold under a variety of names including Lipitor (atorvastatin), Zocor (simvastatin), Mevacor (lovastatin) and Pravachol … csotool airfrance.frWebb1 feb. 1994 · Twenty elderly patients (14 women, 6 men) with primary hypercholesterolemia (total cholesterol >260 mg/dl) were treated for 42 months with simvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor. Mean age was 69 ± 3 years (range, 65 to 72 years). csotong.spc.co.kr/ealing choral society concertsWebb2 sep. 2013 · The PROspective Study of Pravastatin in the Elderly at Risk (PROSPER) was a clinical trial in which 5804 men (n = 2804) and women (n = 3000) aged 70–82 years with a history of, or risk factors for, vascular disease were randomised to treatment with pravastatin (40 mg per day) or placebo. ealing choral society twitter